Form D — TCM Life Science Inc.
0002160964-26-000001 · filed Oct 26, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- —
- Reported amount sold
- $16,666
- Minimum investment
- $0
- Investors
- 2
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- TCM Life Science Inc.
- CIK
- 2160964
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2026
- Address
- 131 CONTINENTAL DRIVE, SUITE 301
NEWARK, DE 19713 - Phone
- 886226972628
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Ya-Chun Wang · Executive OfficerNewark, DE Find on LinkedIn ↗
-
Huan-Chin Hsu · DirectorNewark, DE Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗